Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.02% on an annualized basi

Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of

Citizens analyst David Turkaly maintains Stryker (NYSE:SYK) with a Market Outperform and lowers t

Stryker NYSE: SYK reported 9% organic sales growth in the second quarter of 2026 and adjusted earnin

RBC Capital analyst Kendall Au maintains Stryker (NYSE:SYK) with a Outperform and lowers the pric

JP Morgan analyst Robbie Marcus maintains Stryker (NYSE:SYK) with a Overweight and lowers the pri

Piper Sandler analyst Matt O'Brien maintains Stryker (NYSE:SYK) with a Overweight and lowers

Stryker tops Q2 estimates as sales regain momentum after a cyber disruption, but narrowed 2026 guida

Truist Securities analyst Richard Newitter maintains Stryker (NYSE:SYK) with a Hold and raises th

U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analys

BTIG analyst Ryan Zimmerman maintains Stryker (NYSE:SYK) with a Buy and lowers the price target f

Organic Sales Growth: 9% for Q2 2026, against a double-digit comparable in Q2 2025.Adjusted EPS: $3.

Stryker Corporation (SYK) Q2 2026 Earnings Call Transcript

The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter en

Stryker (SYK) came out with quarterly earnings of $3.69 per share, beating the Zacks Consensus Estim

U.S. medical device maker Stryker on Thursday beat Wall Street estimates for second-quarter results,

The medical technology company reported a profit of $1.28 billion and and said it has made progress

Stryker (NYSE:SYK) reported quarterly earnings of $3.69 per share which beat the analyst consensus e

Portage, Michigan, July 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results f

Medical product makers face Q2 margin pressure from tariffs and inflation even as demand stays stron

Investors interested in stocks from the Medical - Products sector have probably already heard of Phi

Besides Wall Street's top-and-bottom-line estimates for Stryker (SYK), review projections for some o

SYK heads into Q2 with robotic surgery momentum, deferred revenue recovery and strong procedure dema

The medical robot maker expects to report a profit of 28 million yuan to 40 million yuan for the fir

Dimensional Fund Advisors LP decreased its position in shares of Stryker Corporation (NYSE: SYK) by

Andra AP fonden lifted its stake in shares of Stryker Corporation (NYSE: SYK) by 30.2% in the first

Assetmark Inc. boosted its position in shares of Stryker Corporation (NYSE: SYK) by 791.0% in the un

Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.04% on an annualized basi

SYK launches Mako RPS, expanding into handheld robotics for total knee replacement and broadening ac

New handheld robotic technology expands the Mako platform and brings Mako robotic-assisted knee repl

Stryker remains a high-quality MedTech compounder despite a rare Q1 miss driven by a temporary cyber

Evercore ISI Group analyst Vijay Kumar maintains Stryker (NYSE:SYK) with a Outperform and lowers

Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.17% on an annualized basi

Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.13% on an annualized basi

Jim Cramer endorsed Vistra, expressed caution on Fair Isaac over AI risks: "I'm not going to

Leerink Partners analyst Mike Kratky maintains Stryker (NYSE:SYK) with a Outperform and lowers th

Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that

Truist Securities analyst Richard Newitter reiterates Stryker (NYSE:SYK) with a Hold and lowers t

Barclays analyst Matt Miksic maintains Stryker (NYSE:SYK) with a Overweight and lowers the price

Stryker Corporation (STK) shares have dropped to a price level that has been resistance. They are al

Canaccord Genuity analyst Kyle Rose maintains Stryker (NYSE:SYK) with a Buy and lowers the price

Citigroup cut RCL's price target, TD Cowen raised COHU's price target, JP Morgan cut SYK&#39

JP Morgan analyst Robbie Marcus maintains Stryker (NYSE:SYK) with a Overweight and lowers the pri

Evercore ISI Group analyst Vijay Kumar maintains Stryker (NYSE:SYK) with a Outperform and lowers

Wells Fargo analyst Larry Biegelsen maintains Stryker (NYSE:SYK) with a Overweight and lowers the

Needham analyst Mike Matson maintains Stryker (NYSE:SYK) with a Buy and lowers the price target f

BTIG analyst Ryan Zimmerman maintains Stryker (NYSE:SYK) with a Buy and lowers the price target f

We are maintaining our full year 2026 guidance of organic net sales growth(2) in the range of 8.0% t